In this dataset (Fig 8A), S100A12 expression was below 11.6 in all of the 17 healthy volunteers (median value 10.01) and same for all of the 4 patients with moderate COVID-19 (median value 9.75), while it was above 11.6 in 4 of the 8 patients (50%) with severe COVID-19 (median value 11.62), and all of the 4 patients (100%) with critical COVID-19 (median value 12.96). The gene discussed is S100A12; the disease is COVID-19.